Osbro Pharmaceutical Private Limited
About Osbro Pharmaceutical Private Limited
Data last updated:
Osbro Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33110PN2013PTC149114. Its GSTIN is 27AABCO9349J1ZY (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Manoj Vasant Golawar and Bharat Jayantilal Oswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 9 Laxmi Niwas Society 893 Sadashiv Peth, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2022, the company reported a revenue of ₹9.34 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹6.92 Lakh (net margin -0.7%) and EBITDA of ₹65.89 Lakh (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 28% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Osbro Pharmaceutical Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No 9 Laxmi Niwas Society 893 Sadashiv Peth, Pune, Maharashtra, India – 411030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Osbro Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Osbro Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Osbro Pharmaceutical Private Limited, buy the company report.
Financials of Osbro Pharmaceutical Private Limited
FY 2025 filings availableOsbro Pharmaceutical Private Limited reported revenue of ₹9.34 Cr (down 11% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 28%. EBITDA rose 814% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹9.34 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹65.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Osbro Pharmaceutical Private Limited, buy the company report.
Board of directors of Osbro Pharmaceutical Private Limited
Osbro Pharmaceutical has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Vasant Golawar | Director | 29 May 2016 | 10 Years 5 Months | Current |
| Bharat Jayantilal Oswal Also directs: United Uprise Lifespaces LLP, Zirconia Ventures LLP, Shankeshwar Uprise LLP and 3 more | Director | 11 Oct 2013 | 13 Years 0 Months | Current |
| Gopal Tukiram Agrawal Also directs: GC Pharma Remedies Private Limited | Director | 29 May 2016 | 10 Years 5 Months | Current |
| Amit Nutanchandra Mehta | Director | 29 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Osbro Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Osbro Pharmaceutical Private Limitedthis company | ₹9.34 Cr (FY 2022) | -₹6.92 Lakh | -0.7% | -11.0% | 2 | Pune, Maharashtra, India |
| Uniqlife Biosciences Private Limited | ₹9.34 Cr (FY 2025) | 18.0% | Agra, Uttar Pradesh, India | |||
| Idealife Healthcare Limited | ₹9.32 Cr (FY 2025) | 11.0% | Kanpur, Uttar Pradesh, India | |||
| Palmo Industrial Silicones Private Limited | ₹9.32 Cr (FY 2025) | 7.0% | Vadodara, Gujarat, India | |||
| Poddar Pharmaceuticals Private Limited | ₹9.25 Cr (FY 2024) | 83.0% | Uttar Pradesh, India |
To see the full peer comparison of Osbro Pharmaceutical Private Limited, buy the company report.
Auditor
Osbro Pharmaceutical Private Limited is audited by GUNDETI NIRMAL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUNDETI NIRMAL & CO | FY 2022 | 138484W |
Shareholding
The shareholding of Osbro Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Osbro Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Oct 2014 | 10533092 | Lonavala Sahakari Bank Limited | ₹50 Lakh | Satisfied | |
| 31 Oct 2014 | 10533093 | Others | ₹1.5 Cr | Satisfied |
To see the full charge records of Osbro Pharmaceutical Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Osbro Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Osbro Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Osbro Pharmaceutical Private Limited has a workforce of 2 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
GST
Osbro Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCO9349J1ZY | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Osbro Pharmaceutical Private Limited, buy the company report.
Recent activity
Osbro Pharmaceutical Private Limited has 10 board changes on record since 2013: 4 appointments and 6 cessations. The latest: Alam Yusuf Mujawar ceased to be Director on 27 Mar 2017.
7 earlier events are in the company report.
Frequently asked questions
Osbro Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 October 2013 (13+ years old) and is registered under CIN U33110PN2013PTC149114.
Osbro Pharmaceutical has 4 current directors:
- Manoj Vasant Golawar - Director
- Bharat Jayantilal Oswal - Director
- Gopal Tukiram Agrawal - Director
- Amit Nutanchandra Mehta - Director
The latest financial statements of Osbro Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Osbro Pharmaceutical is 27AABCO9349J1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Osbro Pharmaceutical is U33110PN2013PTC149114. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Osbro Pharmaceutical was incorporated on 11 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Osbro Pharmaceutical by revenue are Uniqlife Biosciences Private Limited, Idealife Healthcare Limited, Palmo Industrial Silicones Private Limited, Poddar Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Alam Yusuf Mujawar ceased to be Director on 27 Mar 2017. Gaurav Bharat Oswal ceased to be Director on 27 Mar 2017. Mayur Pravinbhai Raval ceased to be Director on 27 Mar 2017. Osbro Pharmaceutical has 10 board changes on record in total.
The registered office of Osbro Pharmaceutical is at Shop No 9 Laxmi Niwas Society 893 Sadashiv Peth, Pune, Maharashtra, India – 411030.
Osbro Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Osbro Pharmaceutical has no open charges and satisfied charges of ₹2 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
